Compressed timelines, complex study protocols, increased regulatory expectations, and new technologies and industry standards are increasing challenges for healthcare companies to expand their treatment portfolios. Also, the lack of current and emerging treatment data...
Clinical Landscape Study: Expanding Treatment Portfolios and Offerings Specific to Crohn’s Disease for a Healthcare Company
read more